Document Detail


Adipose tissue: a new source for cardiovascular repair.
MedLine Citation:
PMID:  19996982     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Along with angiogenesis and gene therapy, stem cell transplantation is one of the newest treatment modalities proposed to improve the outcome of patients with heart failure or infarction. In this context, much interest has stemmed from experimental studies showing that cardiac transfer of unfractionated or partially purified bone marrow cells, or stem cells and progenitor cells derived from the bone marrow or peripheral blood, can enhance functional recovery after an acute myocardial infarction. On the basis of these data, stem cells and progenitor cells derived from the bone marrow have been proposed for use in the repair of cardiac tissue after acute myocardial infarction in patients. However, the relatively low abundance, small tissue volume, difficult accessibility and disease-related malfunction of bone marrow-derived stem cells make their clinical usefulness difficult in some situations. Recently it has been shown that adipose tissue contains a population of adult multipotent mesenchymal stem cells and endothelial progenitor cells that, in cell culture conditions, have extensive proliferative capacity and are able to differentiate into several lineages, including endothelial cells, smooth muscle cells and cardiomyocytes. The similarities between stem cells extracted from the bone marrow and the adipose tissue suggest the potential for the adipose tissue to act as an alternative, and perhaps preferable, cell source for repairing damaged tissues, such as the ischemic or infarcted heart. In this review we discuss molecular and functional characterization, preclinical results and currently ongoing clinical trials using adipose-derived stem cells in cardiovascular repair.
Authors:
Rosalinda Madonna; Raffaele De Caterina
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Journal of cardiovascular medicine (Hagerstown, Md.)     Volume:  11     ISSN:  1558-2035     ISO Abbreviation:  J Cardiovasc Med (Hagerstown)     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2009-12-25     Completed Date:  2010-03-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101259752     Medline TA:  J Cardiovasc Med (Hagerstown)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  71-80     Citation Subset:  IM    
Affiliation:
Institute of Cardiology and Center of Excellence on Aging, G. d'Annunzio University, Chieti, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adipose Tissue / cytology*
Adult Stem Cells / classification*,  transplantation
Animals
Cell Differentiation*
Clinical Trials as Topic
Heart Diseases / therapy*
Humans
Multipotent Stem Cells / classification
Myocytes, Cardiac / cytology*
Stromal Cells / classification

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Calcified anterior myocardial infarction depicted by cardiac MRI.
Next Document:  A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patie...